FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Cartesian Growth Corporation II Stock AnalysisComprehensive stock analysis for Cartesian Growth Corporation II (RENEF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisRENEF
RENEF
Cartesian Growth Corporation II
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
RENEF
Home🔹Stocks🔹Cartesian Growth Corporation II

Cartesian Growth Corporation II

🇺🇸RENEF•PNK

Cartesian Growth Corporation II

🇺🇸RENEF•PNK
Sentiment

Your view on RENEF

Sentiment
Your view
RENEF
Cartesian Growth Corporation II
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
RENEF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Cartesian Growth Corporation II

Industry
Shell Companies
Sector
Financial Services
CEO
Peter Michael Yu
Headquarters
505 Fifth Avenue, New York, NY, US
Industry
Shell Companies
Sector
Financial Services
CEO
Peter Michael Yu
Headquarters
505 Fifth Avenue, New York, NY, US
Description

Cartesian Growth Corporation II currently lacks significant ongoing business activities.

Established in New York, New York, in 2021, its core objective is to execute a business combination, which may take various forms such as a merger, asset or share acquisition, reorganization, or other similar strategic transaction with one or more existing enterprises.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Cartesian Growth Corporation II, and the rating behind it. RENEF last traded at $12.71, 105.9× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Cartesian Growth Corporation II. Starting points for Cartesian Growth Corporation II: P/E 105.9, EPS $0.15, beta -0.01 — an Shell Companies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Cartesian Growth Corporation II. Cartesian Growth Corporation II does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Cartesian Growth Corporation II. Trailing twelve-month EPS for Cartesian Growth Corporation II stands at $0.15. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Cartesian Growth Corporation II. Cartesian Growth Corporation II has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Cartesian Growth Corporation II valued side by side against its closest peers. Cartesian Growth Corporation II is measured against Shell Companies peers within the Financial Services sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Cartesian Growth Corporation II, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Cartesian Growth Corporation II executives and directors. Shares of Cartesian Growth Corporation II have traded between $12.00 and $12.71 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Cartesian Growth Corporation II. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Cartesian Growth Corporation II. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Cartesian Growth Corporation II. Coverage tracks Cartesian Growth Corporation II within Shell Companies (Financial Services). Press releases and market coverage, newest first.

Peer companies

  • ICU — SeaStar Medical Holding Corporation

More Shell Companies companies

  • AACP — Apogee Acquisition Corp Class A Ordinary Shares
  • AACPR — Apogee Acquisition Corp
  • AACPU — Apogee Acquisition Corp Units
  • AACPW — Apogee Acquisition Corp
  • ABVN — ABV Consulting, Inc.
  • ACAA — Averin Capital Acquisition Corp.
  • ACAAU — Averin Capital Acquisition Corp. Units
  • ACBD — Annabidiol Corp.
  • ACGC — ACP Holdings Acquisition Corp. Class A Ordinary Shares
  • ACGCW — ACP Holdings Acquisition Corp. Warrants
  • ADAC — American Drive Acquisition Company Class A Ordinary Shares
  • ADACU — American Drive Acquisition Company

News

Latest Market News